Paul Gilman, MD, Oncologist. “Practicing any area of oncology or cancer care today is very different than it was just a few years ago. It used to be that you would see a patient, evaluate their cancer, come up with what you felt was the best treatment plan for that patient and proceed with your treatment. And now, as it exists, with payers looking and scrutinizing every step of the way, it has come storming into clinical practice and really dominates what we do on a day-to-day basis. And basically it has meant that we actually have to employ staff whose job it is really just to deal with payers and make sure that the proper pre-certifications and prior authorizations are all attained.”
“So with eviti it’s very different, because here’s a platform that is built on medical literature; is built on evidence; is built on looking what is appropriate for cancer care patients and then provides a way for a physician to go in and be able to look at appropriate regimens – it really helps to make it a more efficient process for the provider and clearly is being done in a fashion far better than what exists today.”
“It’s crucial to a practicing oncologist before you start a patient on a treatment, the implications are such that going forward with treatment with any sort of uncertainty can be devastating to a practice.”
“It’s not just a matter of trying to contain costs; it’s a matter of really looking at the value of our therapies and being sure that what we’re doing makes sense clinically. And I think as a result, the care of our patients is ultimately going to benefit from this.”
“I think it’s a great product. It really provides, not just simply a way of ensuring reimbursement, but really provides an important tool to a practicing oncologist.”
